Relay Therapeutics, Inc. (RLAY) Insider Trading

Over the last 3 months, RLAY insiders made 0 open-market buys and 9 sales, a net sale of -$3.3M (SEC Form 4). Over the last 6 months, 174 institutions increased and 112 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
9
Net (3m)
-$3.3M
Insider trades by month Buys Sells
Nov
Jan
Mar
Apr
May
Jun
Context3-month price +88%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jun 24, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell17,717$17.01
Jun 24, 2026Catinazzo Thomasofficer: Chief Financial OfficerOption51,560$4.45
Jun 24, 2026Bergstrom Donald Aofficer: President, R&DOption93,456$4.12
Jun 24, 2026Bergstrom Donald Aofficer: President, R&DSell93,456$16.94
Jun 24, 2026Catinazzo Thomasofficer: Chief Financial OfficerOption61,563$5.22
Jun 24, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell51,560$16.97
Jun 24, 2026Catinazzo Thomasofficer: Chief Financial OfficerOption56,323$5.04
Jun 10, 2026COATS LONNELdirectorGrant32,947$14.09
Jun 10, 2026Mazumdar ClairedirectorGrant32,947$14.09
Jun 10, 2026Dable Habib JdirectorGrant32,947$14.09
Jun 10, 2026HILL LINDA AdirectorGrant32,947$14.09
Jun 10, 2026Borisy AlexisdirectorGrant32,947$14.09
Jun 10, 2026INGRAM DOUGLAS SdirectorGrant32,947$14.09
Jun 10, 2026Murcko MarkdirectorGrant32,947$14.09
May 14, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell17,717$12.86
Apr 30, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell972$14.79
Apr 30, 2026Rahmer Peterofficer: See remarksSell753$14.79
Apr 30, 2026Bergstrom Donald Aofficer: President, R&DSell1,490$14.79
Apr 9, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell17,717$13.01
Apr 9, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell1,800$15.00
Apr 9, 2026Catinazzo Thomasofficer: Chief Financial OfficerOption1,800$5.22
Mar 11, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell17,717$10.06
Jan 29, 2026Rahmer Peterofficer: See remarksSell1,354$8.45
Jan 29, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell1,695$8.45
Jan 29, 2026Bergstrom Donald Aofficer: President, R&DSell2,686$8.45
Jan 29, 2026Rahmer Peterofficer: See remarksGrant994$2.99
Jan 29, 2026Rahmer Peterofficer: See remarksSell11,684$7.62
Jan 29, 2026Catinazzo Thomasofficer: Chief Financial OfficerSell13,820$7.62
Jan 29, 2026Bergstrom Donald Aofficer: President, R&DSell18,895$7.62
Jan 15, 2026Patel Sanjivdirector, officer: President and CEOGrant1,450,000$7.94

Source: RLAY SEC Form 4 filings, latest Jun 24, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their RLAY positions over the last 6 months (SEC Form 13F).

Increased
174
New positions
94
Reduced
112
Sold out
55
Largest moves
InstitutionActionSharesFiled
SB INVESTMENT ADVISERS (UK) LTDUnchanged27.9MMay 18, 2026
SB INVESTMENT ADVISERS (UK) LTDUnchanged27.9MFeb 18, 2026
PERCEPTIVE ADVISORS LLCIncreased19.5MMay 29, 2026
COMMODORE CAPITAL LPUnchanged17.0MMay 15, 2026
COMMODORE CAPITAL LPUnchanged17.0MFeb 17, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position14.8MMay 15, 2026
CASDIN CAPITAL, LLCIncreased14.4MMay 15, 2026
POINT72 ASSET MANAGEMENT, L.P.Reduced13.9MFeb 17, 2026
BLACKROCK, INC.Reduced13.2MFeb 12, 2026
CASDIN CAPITAL, LLCIncreased13.0MFeb 17, 2026
BLACKROCK, INC.Reduced13.0MMay 13, 2026
VANGUARD GROUP INCIncreased9.7MJan 29, 2026
BELLEVUE GROUP AGReduced8.3MFeb 17, 2026
BELLEVUE GROUP AGReduced7.8MMay 15, 2026
STATE STREET CORPIncreased6.4MFeb 13, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.